Clinicopathological importance of colorectal medullary carcinoma
- 9 October 2019
- journal article
- research article
- Published by Springer Nature in European Surgery
- Vol. 51 (6) , 308-314
Abstract
No abstract availableKeywords
This publication has 37 references indexed in Scilit:
- Defective Mismatch Repair Status as a Prognostic Biomarker of Disease-Free Survival in Stage III Colon Cancer Patients Treated with Adjuvant FOLFOX ChemotherapyClinical Cancer Research, 2011
- The Prognostic Significance of Tryptophanyl-tRNA Synthetase in Colorectal CancerCancer Epidemiology, Biomarkers & Prevention, 2009
- Microsatellite Instability Predicts Improved Response to Adjuvant Therapy With Irinotecan, Fluorouracil, and Leucovorin in Stage III Colon Cancer: Cancer and Leukemia Group B Protocol 89803Journal of Clinical Oncology, 2009
- Differentiating the undifferentiated: immunohistochemical profile of medullary carcinoma of the colon with an emphasis on intestinal differentiationHuman Pathology, 2009
- The biochemical basis of microsatellite instability and abnormal immunohistochemistry and clinical behavior in Lynch Syndrome: from bench to bedsideFamilial Cancer, 2007
- Microsatellite instability in poorly differentiated adenocarcinomas of the colon and rectum: relationship to clinicopathological featuresJournal of Clinical Pathology, 2007
- CpG island methylator phenotype underlies sporadic microsatellite instability and is tightly associated with BRAF mutation in colorectal cancerNature Genetics, 2006
- Hypermethylation of the hMLH1 promoter with absent hMLH1 expression in medullary-type poorly differentiated colorectal adenocarcinoma in the elderlyLaboratory Investigation, 2004
- Loss of CDX2 Expression and Microsatellite Instability Are Prominent Features of Large Cell Minimally Differentiated Carcinomas of the ColonThe American Journal of Pathology, 2001
- Histopathological Identification of Colon Cancer with Microsatellite InstabilityThe American Journal of Pathology, 2001